“Breaking Down the Numbers: Utah Medical’s Q4 Earnings Take a Dip, Stock Falls 5%”

UTMD’s Q4 EPS drops 27.4% year over year, revenues fall 25.8% on weak PendoTECH sales The Financial Struggles of UTMD Utah Medical Products, Inc. (UTMD) recently reported a significant decrease in their fourth quarter earnings per share (EPS), which dropped by 27.4% compared to the previous year. Additionally, the company’s revenues fell by 25.8% due…

Read More

“Breaking Barriers: Euro Manganese Celebrates Major Permitting Milestone for Chvaletice Project in 2025”

Euro Manganese Inc. Secures Mining Lease Permit for Chvaletice Manganese Project Exciting News for Euro Manganese Inc. In a recent announcement, Euro Manganese Inc. shared that its subsidiary, Mangan Chvaletice s.r.o., has successfully obtained the Determination of Mining Lease permit for the Chvaletice Manganese Project in the Czech Republic. This significant milestone represents a major…

Read More

RIGL Stock Soars: A 41.4% Gain in a Year – Is It Time to Buy or Sell?

Rigel Pharmaceuticals: A Beacon of Hope in the Healthcare Industry 2024 was a remarkable year for Rigel Pharmaceuticals (NASDAQ: RIGL). The biotech company, known for its innovative approach to immunology and oncology research, reported impressive financial results and made significant strides in drug development. As we look forward to 2025, the future seems bright for…

Read More